SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is the main focus, with traders weighing the amended upper-limb data and recent FDA rare-disease messaging against concerns about the prior review and unresolved efficacy questions. INOVIOs approval has added optimism as a possible regulatory read-through, while bullish speculation about launch-related hiring is widely discussed but is not confirmation of CAPR approval.

Solana (SOL) is a cryptocurrency launched in 2020. Solana has a current supply of 636,822,022.65079832 with 590,150,211.79771733 in circulation. The last known price of Solana is 94.05303263 USD and is down -1.56 over the last 24 hours. It is currently trading on 1189 active market(s) with $1,556,044,818.54 traded over the last 24 hours. More information can be found at https://solana.com.

Solana

Solana is under pressure amid a broader crypto selloff, with traders linking market jitters to the reported Binance security incident and concerns about exchange confidence. The community is split between bearish technical readings and fears of further losses, and dip buyers who are adding or staking SOL.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,809.831273 with 281,866,746.118905 in circulation. The last known price of OFFICIAL TRUMP is 1.73532194 USD and is up 9.97 over the last 24 hours. It is currently trading on 744 active market(s) with $259,407,006.57 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

Discussion centers on the TRUMP meme coins steep decline and allegations that it was a pump-and-dump benefiting insiders. Bearish criticism dominates, though some holders still speculate about a rebound or short squeeze.

Cardano (ADA) is a cryptocurrency launched in 2017. Cardano has a current supply of 44,994,665,205.855202 with 36,823,860,963.224877 in circulation. The last known price of Cardano is 0.19280151 USD and is up 0.00 over the last 24 hours. It is currently trading on 1752 active market(s) with $154,401,668.14 traded over the last 24 hours. More information can be found at https://www.cardano.org.

Cardano

Cardanos volatile price action and difficulty sustaining rallies dominate the discussion, with many traders calling the weakness a sign of further downside. Others are accumulating and looking for a technical rebound or breakout, leaving sentiment sharply divided.

XPeng, Inc. is a global physical AI company, which engages in bringing artificial intelligence into the physical world to reshape future mobility and smart living. It developed a full-stack physical AI architecture spanning Turing AI chips, world foundation models, and integrated software and hardware applications. The firm's product portfolio includes smart EVs, robotaxis, and humanoid robots. The company's sales and services drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. XPeng, Inc. was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPengs record October deliveries, led by rapid overseas growth, are driving discussion, while traders question whether rising volume will translate into stronger margins and whether the company can meet its Q4 goals. The delivery news is being weighed against a prolonged selloff and broader weakness in Chinese EV stocks.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOI is drawing attention amid a sharp selloff alongside other AI-optics stocks, with traders pointing to broader tech weakness and concerns about AI spending, financing and possible further dilution rather than a clear company-specific trigger. Bulls call the drop an overreaction and cite continued data-center optics demand, while bears remain worried about volatility and the upcoming earnings report.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckins scheduled third-quarter results are driving positioning, with bulls anticipating an earnings-related rebound and bears expecting further weakness. Traders also debate the stocks prolonged range-bound performance, speculating that buybacks or a future U.S. relisting could improve sentiment, though no relisting timeline is confirmed.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to a fresh 52-week high ahead of the expected Q3 report has put TGTX in focus, with traders citing BRIUMVIs growth and positioning for upcoming results. Buyout and short-squeeze speculation is also prominent, but the timing of earnings is unconfirmed and no acquisition is confirmed.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gileads Q3 results and raised product-sales outlook are driving attention, with traders pointing to strength in its HIV business and prevention products. The upbeat reaction has accompanied a breakout to fresh 52-week highs, though some investors remain cautious after the run-up and acquisition-related accounting charges.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

APPs steep, prolonged selloff has traders focused on the forthcoming earnings report and whether weakness in advertising signals from peers will affect results or guidance. Bulls argue the decline has outpaced the companys fundamentals, while bears point to ad-market concerns, analyst downgrades, and the risk of further losses if the report disappoints.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$RKLB     Neuron will happen, just be patient. Peter Beck wants to get it right the first time, and he probably will.     https://spaceflightnow.com/2026/08/10/window-for-2026-launch-debut-of-rocket-labs-neutron-rocket-is-narrowing-as-development-continues/

Robert

WilliamTheButcher

AM Gomez

Lorin Bird

Luke

Rocket Lab's anticipated debut of its medium-lift Neutron rocket may end up slipping beyond this year and into 2027. In a filing to the U.S. Securities and Exchange Commission (SES) ahead of is second quarter 2026 earnings call with investors on Tuesday, the company noted that it's working through various qualification testing and made "significant milestones across the Neutron program."

Spaceflightnow

Window for 2026 launch debut of Rocket Lab's Neutron rocket 'is narrowing' as development continues

StockTwits Web

Rocket Lab USA Inc

     Neuron will happen, just be patient. Peter Beck wants to get it right the first time, and he probably will.     